UBS Group »

Biondvax Pharmaceuticals shares owned by UBS Group

Quarter-by-quarter ownership of Biondvax Pharmaceuticals (SCNI) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Biondvax Pharmaceuticals

Jul 2024Aug 2024Sep 2024Oct 2024Nov 2024Dec 2024Jan 2025020k40k60k80k05k10k15k20k25k
Value ($)Share countHistorical SCNI position of UBS Group Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Biondvax Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biondvax Pharmaceuticals by UBS Group

Quarter filed Position value Share count Share price at filing
2024-12-31 $79k 24k 3.35
2024-09-30 $104 30 3.47
2024-06-30 $583 211 2.77

More positions owned by UBS Group

Apple Call Option (AAPL)
NVIDIA Corporation Call Option (NVDA)
Microsoft Corporation Call Option (MSFT)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Amazon Call Option (AMZN)
Broadcom Call Option (AVGO)
Meta Platforms Cl A Call Option (META)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
JPMorgan Chase & Co. Call Option (JPM)
Tesla Motors Call Option (TSLA)
Ubs Group SHS Call Option (UBS)
Alphabet Cap Stk Cl C Call Option (GOOG)
Ishares Tr Russell 2000 Etf (IWM)
Visa Com Cl A Call Option (V)

View all positions for UBS Group

Top funds holding Biondvax Pharmaceuticals

UBS Group
Rhumbline Advisers
Morgan Stanley
Credit Agricole

View all funds holding Biondvax Pharmaceuticals